BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3334965)

  • 1. Different antitumor mechanisms of interferon-alpha in the treatment of hairy cell leukemia and renal cell cancer.
    Porzsolt F; Digel W; Jacobsen H; Mittnacht S; Kirchner H; Heimpel H
    Cancer; 1988 Jan; 61(2):288-93. PubMed ID: 3334965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient IFN alpha production in hairy cell leukemia.
    Porzsolt F; Janik R; Heil G; Brudler O; Raghavachar A; Scholz S; Papendick U; Heimpel H
    Blut; 1986 Mar; 52(3):185-90. PubMed ID: 3006840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should alpha interferon be used as primary treatment for hairy cell leukemia? Italian Cooperative Group for Hairy Cell Leukemia.
    Capnist G; Federico M; Chisesi T; Resegotti L; Pagnucco G; Castoldi GL; Lamparelli T; Frassoldati A; Guarnaccia C; Leoni P
    Leuk Res; 1991; 15(6):419-26. PubMed ID: 1861528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined effects of interferon and 2'-deoxycoformycin on 2',5'-oligoadenylate synthetase and adenosine deaminase in hairy cell and chronic lymphocytic leukemia cells.
    Triozzi PL; Avery KA; Grever MR; Kraut EH
    J Interferon Res; 1990 Oct; 10(5):535-40. PubMed ID: 2273300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
    Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
    Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of interferon-alpha on hairy cell leukemia: expression of specific receptors and (2'-5')oligo (A) synthetase in tumor cells from sensitive and resistant patients.
    Billard C; Ferbus D; Sigaux F; Castaigne S; Degos L; Flandrin G; Falcoff E
    Leuk Res; 1988; 12(1):11-8. PubMed ID: 2965776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferative response of hairy cells to B cell growth factor (BCGF): in vivo inhibition by interferon-alpha and in vitro effects of interferon-alpha, -beta, and -gamma.
    Genot E; Billard C; Sigaux F; Mathiot C; Degos L; Falcoff E; Kolb JP
    Leukemia; 1987 Aug; 1(8):590-6. PubMed ID: 2444836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha interferon production in patients with hairy cell leukemia: correlations with disease activity and remission status.
    Lepe-Zuniga JL; Quesada JR; Baron S; Reuben J; Gutterman JU
    Hematol Pathol; 1987; 1(3):157-65. PubMed ID: 3150846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of clinical efficacy and toxicity of conventional and optimum biological response modifying doses of interferon alpha-2C in the treatment of hairy cell leukemia: a retrospective analysis of 39 patients.
    Gastl G; Werter M; De Pauw B; Nerl C; Aulitzky W; von Lüttichau I; Tilg H; Thaler J; Lang A; Abbrederis K
    Leukemia; 1989 Jun; 3(6):453-60. PubMed ID: 2725061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reconstitution of endogenous interferon a by recombinant interferon in hairy cell leukemia.
    Shehata M; Schwarzmeier JD; Nguyen ST; Hilgarth M; Berger R; Hubmann R; Kickmaier S; Decker T
    Cancer Res; 2000 Oct; 60(19):5420-6. PubMed ID: 11034083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-induced 2'-5' oligoadenylate synthetase during interferon-alpha therapy in homosexual men with Kaposi's sarcoma: marked deficiency in biochemical response to interferon in patients with acquired immunodeficiency syndrome.
    Preble OT; Rook AH; Steis R; Silverman RH; Krause D; Quinnan GV; Masur H; Jacob J; Longo D; Gelmann EP
    J Infect Dis; 1985 Sep; 152(3):457-65. PubMed ID: 2993441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of interferon antibodies during prolonged continuous interferon-alpha 2a therapy in hairy cell leukemia.
    Steis RG; Smith JW; Urba WJ; Venzon DJ; Longo DL; Barney R; Evans LM; Itri LM; Ewel CH
    Blood; 1991 Feb; 77(4):792-8. PubMed ID: 1704264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
    Ho AD; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont AM; Prümmer O; Stryckmans P
    J Clin Oncol; 1989 Oct; 7(10):1533-8. PubMed ID: 2789273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splenectomy following complete response to alpha interferon (IFN) therapy in patients with hairy cell leukemia (HCL): results of the HCL88 protocol. Italian Cooperative Group for the Study of Hairy Cell Leukemia (ICGHCL).
    Damasio EE; Frassoldati A
    Leuk Lymphoma; 1994; 14 Suppl 1():95-8. PubMed ID: 7820061
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of advanced renal cell cancer with recombinant interferon alpha as a single agent and in combination with medroxyprogesterone acetate. A randomized multicenter trial.
    Porzsolt F; Messerer D; Hautmann R; Gottwald A; Sparwasser H; Stockamp K; Aulitzky W; Moormann JG; Schumacher K; Rasche H
    J Cancer Res Clin Oncol; 1988; 114(1):95-100. PubMed ID: 2965154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for an association between hairy cell leukemia and renal cell and colorectal carcinoma.
    Nielsen B; Braide I; Hasselbalch H
    Cancer; 1992 Oct; 70(8):2087-90. PubMed ID: 1394039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.